A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Public ClinicalTrials.gov record NCT06730347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multicohort Study to Evaluate Lorigerlimab in Participants With Advanced Solid Tumors
Study identification
- NCT ID
- NCT06730347
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MacroGenics
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
- Clear Cell Adenocarcinoma of Cervix
- Clear Cell Adenocarcinoma of Fallopian Tube
- Clear Cell Adenocarcinoma of Ovary
- Clear Cell Adenocarcinoma of Peritoneum
- Clear Cell Adenocarcinoma of Uterus
- Clear Cell Adenocarcinoma of Vagina
- Clear Cell Adenocarcinoma of Vulva
- Endometrial Cancer
- Platinum-Resistant Fallopian Tube Carcinoma
- Platinum-Resistant Primary Peritoneal Carcinoma
- Platinum-resistant Ovarian Cancer
Interventions
- Lorigerlimab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jul 31, 2027
- Last update posted
- Mar 4, 2026
2025 – 2027
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA | Los Angeles | California | 90095 | Recruiting |
| Ochsner MD Anderson Cancer Center | New Orleans | Louisiana | 70115 | Recruiting |
| START Midwest | Grand Rapids | Michigan | 49546 | Recruiting |
| West Penn Allegheny Health | Pittsburgh | Pennsylvania | 15224 | Recruiting |
| Mays Clinic | Houston | Texas | 77030 | Recruiting |
| START San Antonio | San Antonio | Texas | 78229 | Recruiting |
| Wisconsin Institute Medical Research- UW Cancer Connect | Madison | Wisconsin | 53705 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06730347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06730347 live on ClinicalTrials.gov.